Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2028-09-17 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 231,444 | $0 | 0 (Direct) | View |
2023-06-12 Option Award | 2023-06-13 6:28 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:01 pm | N/A 2032-06-13 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 20,250 | $0 | 20,250 (Direct) | View |
2022-05-31 Disposition | 2022-05-31 10:12 am | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 36,778 | $0 | 0 (Direct) | View |
2021-06-16 Option Award | 2021-06-21 9:24 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 10,030 | $0 | 10,030 (Direct) | View |
2021-06-11 Option Award | 2021-06-14 7:13 pm | N/A 2031-06-11 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 20,250 | $0 | 20,250 (Direct) | View |
2021-06-10 Option Award | 2021-06-11 9:02 pm | N/A 2031-06-10 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 42,223 | $0 | 42,223 (Direct) | View |
Ownership | 2020-12-02 9:11 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 0 | $0 | 165,944 (Direct) | View |
Ownership | 2020-08-06 9:04 pm | 2020-03-27 2028-03-27 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 0 | $0 | 26,748 (Direct) | View |
2020-06-04 Option Award | 2020-06-05 5:03 pm | N/A 2030-06-04 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 40,138 | $0 | 40,138 (Direct) | View |